Cargando…
Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy
Margaret McNairy and colleagues highlight the need for clinical decision tools to help identify HIV patients who would benefit from tailored services to avoid poor outcomes such as death and loss to follow-up.
Autores principales: | McNairy, Margaret L., Abrams, Elaine J., Rabkin, Miriam, El-Sadr, Wafaa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395167/ https://www.ncbi.nlm.nih.gov/pubmed/28419097 http://dx.doi.org/10.1371/journal.pmed.1002278 |
Ejemplares similares
-
Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda
por: Rosen, Sydney, et al.
Publicado: (2016) -
Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011) -
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
por: Wilkes, Michael, et al.
Publicado: (2008) -
Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences
por: Rosen, Sydney, et al.
Publicado: (2005) -
Antiretroviral Therapy for Refugees and Internally Displaced Persons: A Call for Equity
por: Mendelsohn, Joshua B, et al.
Publicado: (2014)